Exelixis: Earnings and Cash Flow Acceleration Create a Tactical Buy Opportunity
Exelixis has posted rapid earnings and free-cash-flow acceleration that the market hasn't fully priced. With EPS of $3.32, trailing P/E ~15x and free cash flow near $912M, the stock looks set to re-rate as new approvals and better-than-expected revenue cadence shift growth expectations. This trade idea targets a mid-term (45 trading days) move to $…